Articles by : Yamini Asthana

Chinese and Russian patents granted to Proa Medical, Inc. for Brella Vaginal Retractor

Chinese and Russian patents granted to Proa Medical, Inc. for Brella Vaginal Retractor

Proa Medical, Inc., has been granted patents in China and Russia for the company’s first product, the Brella Vaginal Retractor. Generally, the company is involved in development of pioneering and practical medical devices with respect to care-technology for women’s health. Earlier on June 9, 2015 Proa Medical was granted a United States patent covering the Brella Vaginal Retractor from the United States Patent and Trademark Office.

Read More


Digital Barcode patent granted to Applied BioCode, Inc. for identification of multiplexed biomarkers or pathogens

Digital Barcode patent granted to Applied BioCode, Inc. for identification of multiplexed biomarkers or pathogens

Applied BioCode announced on February 9th, 2016 the grant of US Patent 9255922 from United Stated Patent and Trademark Office. Briefly, the granted patent describes the material and method of a digital barcode, and the specialty of which being 1,000 times smaller than the conventional barcodes. The digital barcode is mainly employed for simultaneous identification of thousands of bacteria, viruses, pathogens, or biomarkers.

Read More


Grant of two international patents to Integral Molecular, Inc. for key Lipoparticle Technology

Grant of two international patents to Integral Molecular, Inc. for key Lipoparticle Technology

On 11th of February 2016, Integral Molecular, Inc. announced the issuance of two key patents in Europe and the U.S, respectively. Integral Molecular, Inc. is a leader in membrane protein antibody discovery and the issuance of patents, EP166038 and US9213027, has further strengthened the company’s rapidly expanding patent portfolio for its Lipoparticle technology.

Read More



Illumina files lawsuits in Europe against Ariosa and The Doctors Laboratory for NIPT patent infringement

Illumina files lawsuits in Europe against Ariosa and The Doctors Laboratory for NIPT patent infringement

Illumina, an American company announced on 7th January 2016 that it has filed two patent infringements lawsuits against five companies in Europe over their use of noninvasive prenatal tests. In the lawsuit, Illumina claims violation of its intellectual property protections.

Illumina’s profile: The American company was founded in April 1998 by David Walt, Larry Bock, John Stuelpnagel, Anthony Czarnik, and Mark Chee with the headquarters located in San Diego, California.

Read More


Four U.S patents in synthetic biology awarded to Gen 9

Four U.S patents in synthetic biology awarded to Gen 9

It was on January 7th 2016, that Gen9, an established company involved in DNA synthesis and assembly technology announced the issuance of four innovative U.S. patents in the ending of 2015. The patents are related to gene synthesis and synthetic biology technologies. It is quite understandable that the awarded patents have further added feathers of success to Gen9’s already extensive intellectual property portfolio encompassing more than 100 patents and with many patents pending.

Read More


An innovative InFill spinal fusion patent for Pinnacle Spine Group

An innovative InFill spinal fusion patent for Pinnacle Spine Group

Pinnacle Spine Group received a patent entitled “Intervertebral Implants and Related Tools,” which is third in the series casing the company’s InFill fusion technology on 22nd December 2015. On an introductory note, Pinnacle Spine Group was established with the “goal of developing innovative medical devices, conceived in the operating room, for surgical procedures of the spine”.

Read More


Two USPTO patents granted to AlloSource for innovations in cartilage repair

Two USPTO patents granted to AlloSource for innovations in cartilage repair

Two United States Patent and Trademark Office (USPTO) patents have been granted to AlloSource on Dec. 29th 2015 for cartilage repair allografts. AlloSource is one of the principal providers of cartilage, cellular, bone, skin and soft-tissue allografts, which are importantly employed in surgical procedures and for wound care to advance the process of healing in patients.

Read More


Canadian patent granted to Orthocell for bioscaffolds

Canadian patent granted to Orthocell for bioscaffolds

A Canadian patent has been granted to Regenerative medicine company, Orthocell Limited for Canadian Patent Application No. 2685146 entitled “Tenocyte containing bioscaffolds and treatments using the same” and the announcement was made on 9th Dec. 2015, Perth, Australia. The patent granted covers the combination of bio-scaffolds and tenocytes, the cells that make up healthy tendons for tendon regeneration.

Read More


Brief overview of medical patents awarded to New York Blood Center scientists for blood supply discoveries and advance vaccine therapies

Brief overview of medical patents awarded to New York Blood Center scientists for blood supply discoveries and advance vaccine therapies

Scientists including Lanying Du, Ph.D.; Francesca Curreli, Ph.D.; Beth Shaz, M.D.; Christopher D. Hillyer, M.D.; Asim K. Debnath, Ph.D.; Sara Lustigman, Ph.D. from the New York Blood Center (NYBC) have been honored with several new patents in 2014 / 15 for numerous projects that are intended to preserve the U.S. blood supply and advance vaccine therapies …

Read More



An USPTO patent granted to Mesoblast Limited for the treatment of heart diseases, stroke and other vascular conditions

An USPTO patent granted to Mesoblast Limited for the treatment of heart diseases, stroke and other vascular conditions

United States Patent and Trademark Office (USPTO) has granted a key patent to Mesoblast Limited (ASX:MSB) (USOTC:MBLTY) casing employment of the Company’s proprietary adult Mesenchymal Precursor Cells (MPCs) for the formation and repair of blood vessels in ischemic tissues. The announcement about the recent patent grant was made on Oct. 27th 2015.

Read More


Human genes are not ‘patentable invention’: verdict by Australia’s top court on BRCA1 gene patent

IP-australia“Can the genes be patented or not has been pondered since the commencement of the Human Genome Project. Numerous questions about whether discovery of a gene is sufficient to claim an invention and whether gene patents promote or asphyxiate research and the clinical use of genomics have been lifted up since then. In a landmark decision in June 2013, the Supreme Court determined that DNA in its natural form cannot be patented”.

The current snippet on BRCA1 gene patent:
The High Court of Australia on 7th October, 2015 collectively invalidated the patent claims of the American biotech firm, Myriad Genetics, Inc. over a gene coding for a BRCA1 protein, which acts as a tumor suppressor. The verdict was in favor of a

Read More


Establishment of Curcumin Resource DataBase (CRDB) – Efforts commendable of Indian Scientists to prohibit False patent claims on Curcumin

In a commendable initiative, world’s first comprehensive open database on curcumin has been created by Indian scientists from Kolkata with an aim to create substitutional innovation strategy and generate public awareness. The Curcumin Resource Database (CRDB) or portal is a collaborative effort of the Indian Institute of Technology-Guwahati (IIT-G), Institute of Advanced Study on Science and Technology (IASST) and the Central University of South Bihar (CUSB), Patna. The entire stream of efforts and struggles to impart security to the celebrity therapeutic component (curcumin) of the golden Indian spice turmeric and much beloved amongst researchers across the sphere been granted a worldwide recognition.

The CRDB team includes;

  • Dr. N.C. Talukdar, Team Leader, Director, Institute of Advanced Study in Science and Technology, Guwahati, Assam.
  • Prof. Utpal Bora, Team Leader, Bioengineering Research Laboratory, Dept. of Biosciences

    Read More


The cryptic case of Rasgulla – Combat for rights over Geographical Indication amogst bengalis and odiyas

The emblematic, soft hearted-cheesy-sugar syrupy filled rasgulla has again become a victim of a bitter debate with respect to its origin and continues to bamboozle its admirers. Both Odisha and West Bengal have been making claims over the origin of the delicacy and attempting to get the geographical indication tag for this mouthwatering sweet.

The debate gained momentum in August this year at the time of the closing of the festival, Nabakalebara (soul transformation of the holy trinity) Rath Yatra in Puri, with Surya Narayan Rath Sharma, a researcher from Jagannath Temple asserting the origin of rasgulla in Puri and further claiming that the delicacy is offered to Gods every year. Surprisingly furthermore, Laxmidhar Pujapanda, Public Relation Officer of the Jagannath temple, claims that the delectable sweet has been part of

Read More


Microfluidics Technology-Based Lab-on-a-Chip Device – A Brief Overview and a Recent Breakthrough Report from Rutgers Engineers

A recently published report in Azonano.com dated 13th September 2015, states development of a breakthrough device that can significantly reduce the cost of sophisticated lab tests for medical disorders and diseases and glorified credit goes to engineers from Rutgers School of Engineering, New Jersey. As proposed, the medical device could reduce cost of sophisticated tests for diseases and medical disorders like HIV, Lyme disease and syphilis.

By definition, a lab-on-a-chip (LOC) is a class of device that integrates and automates multiple laboratory techniques into a system that fits on a chip up to a maximum of a few square centimeters in size. LOCs deal with the handling of extremely small fluid volumes down to less than pico liters and the devices are regarded as a compartment of Micro-electro-mechanical systems (MEMS) devices

Read More


Caprotec Bioanalytics, A German company bags US Patent for CCMS Proteome analysis technology

It was on August 20, 2015, that Caprotec Bioanalytics, GmbH proclaimed issue of patent by United States Patent Office (No. US 9,034,789) entitled “Capture Compounds, Collections Thereof and Methods for Analyzing the Proteome and Complex Compositions” on ground-breaking Capture Compound Mass Spectrometry (CCMS) technology. Caprotec, founded in 2007 by serial entrepreneur Prof. Hubert Koester is based in Berlin and the newly granted patent to this company harmonizes the company’s patent assortment of more than 40 issued patents in countries including the European Union, Canada, Australia, Singapore, Hong Kong, Japan, Israel and India. The company’s investors encompass a jumble of private and institutional organizations including Creathor Venture, IBB Beteiligungsgesellschaft (VC Fond Berlin), LBBW Venture Capital, KfW (ERP Startfonds) and prominent business people from the life sciences communities. The main target of

Read More


Indian laboratory CSMCRI-CSIR gains triumph over battle to patent cheaper Iodized salt

Once again in the successful row of winning patent battles based on traditional knowledge, India has attained global attention as an Indian public sector laboratory from Bhavnagar has gained victory over an exceptional patent battle on a method of producing iodized salt against a huge multi-national company, Hindustan Unilever Limited (HUL). Both in a humble and pompous sense, this victory is being considered as the 21st century ‘Salt Satyagraha’, about which even our father of nation, Mahatma Gandhiji would be feeling incredibly self-righteous. The Central Salt and Marine Chemicals Research Institute (CSMCRI) has humbled the giant multi-national corporation Hindustan (HUL) to reinstate control over a patent to efficiently make the everyday commodity, iodized salt. Eventually, the CSMCRI managed to put a stop to an exertion to extort control over a

Read More


Swiss Drug Maker-Roche Patent Claims On Valcyte Faces Rejection All Over Again In India

The Indian Patent Office in a verdict on July 1, 2015, for the second time, rejected Swiss drug maker Roche’s patent claims on Valganciclovir or Valcyte, used to treat an eye infection, which commonly affects patients suffering from acquired immune deficiency syndrome (AIDS). The decision was made mainly on grounds of “obviousness” and Sec 3(d) of the Indian Patent Act, which refutes patent claims to additional innovations in the absence of corroboration for therapeutically momentous significant effectiveness.

A spokesperson from Roche, India informed the media that the company is taking into account the alternatives based on the latest decision on the drug and will act in response at the earliest.

Earlier in 2010, the patent authority had given permission to certain Indian drug makers including Cipla, Matrix (presently named as Mylan) and

Read More


Patent Granted To Nutech Mediworld For Ground-Breaking Developments In Human Embryonic Stem Cell Technology To Treat Incurable Diseases In Malaysia

Indian medical innovation is over again in glare of publicity in biotechnology sector as a leader in stem cell therapy and the credit goes to Dr Geeta Shroff, Founder and Medical Director, Nutech Mediworld in being granted 66th patent on ground breaking human embryonic stem cell technology to treat incurable diseases in Malaysia. Earlier in 2015, Dr Shroff’s technology was officially granted its 65th patent in Israel and the technology has already been granted patents in countries like Japan, Singapore, South Korea, USA, Australia and New Zealand. It is worth mentioning here that the incredible team has an additional 82 patents in different countries at varying stages of evaluation. Dr. Shroff, an infertility expert in in-vitro fertilization (IVF), initiated her research on human embryonic stem cells in 1999 and is

Read More


Traditional Knowledge Digital Library (TKDL) Database: A brief overview on its origin and its crucial role behind India wedging Colgate-Palmolive Patents for typically consumed spices

Gaining an insight into Traditional Knowledge Digital Library (TKDL) database will make one realize the magnitude and significance of Indian traditional medicinal system and heritage. Since primeval time, India has possessed an affluent traditional knowledge, which refers to knowledge inherent in aboriginal communities on diverse ways and means practiced to treat diseases, which have distressed people. This knowledge has generally been passed from generations to generations through oral means. Our prehistoric classical and other literature, encompass such information, which are often unapproachable by a common man and even when accessible remain to be exceptionally understood. Certification and documentation of existing traditional knowledge, available in public domain, on various traditional systems of medicine has gained importance to preserve the autonomy of Indian traditional knowledge and to protect it from being embezzled

Read More


University of California-Berkeley, Harvard or MIT: Who owns billions of dollars worth CRISPR-CAS9 mediated gene-editing technology?

Genome editing, also referred to as genome editing with engineered nucleases (GEEN) is a category of genetic engineering, in which DNA is inserted, replaced, or removed from a genome using artificially engineered nucleases, or “molecular scissors.” The nucleases create specific double-stranded break (DSBs) at desired locations in the genome, and harness the cell’s endogenous mechanisms to repair the induced break by natural processes of homologous recombination (HR) and nonhomologous end-joining (NHEJ). Amongst four specific families of engineered nucleases, CRISPR/Cas system has gained immense importance in recent years. Generally, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPRs) and CRISPR-associated (Cas) proteins are found in many bacteria and most archaea. With respect to high flexibility and specific targeting, it is possible to manipulate and redirect CRISPR-Cas systems and render them as powerful tools

Read More